Evidence map›Paper›PMID 40934267›Full record

ArticlePLoS computational biology2025

A curriculum learning approach to training antibody language models.

Sarah M Burbach, Bryan Briney

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Data-optimal scaling of paired antibody language models.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sarah M BurbachDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.ORCID 0000-0002-8929-5727
Bryan BrineyDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.ORCID 0000-0001-9535-2866

Funding

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antiviralsUM1AI144462 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2019 to 2025
$201.6M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONIA JAIN · 1994 to 2026
$78.4M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura D. Hughes · 2018 to 2026
$32.0M
The Multi-omics Vaccine Evaluation (MOVE) ConsortiumP01AI177683 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Bryan Briney · 2023 to 2026
$9.0M
Genetic, structural and functional profiling of the human antibody response to arenavirus infectionR01AI171438 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Raiees Ahmad Andrabi, Bryan Briney · 2022 to 2026
$4.4M
NIAID NIH HHS P01 AI177683NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI171438NIAID NIH HHS U19 AI135995NIAID NIH HHS UM1 AI144462
6 · The paper itself

Abstract

There is growing interest in pre-training antibody language models (AbLMs) with a mixture of unpaired and natively paired sequences, seeking to combine the proven benefits of training with natively paired sequences with the massive scale of unpaired antibody sequence datasets. However, given the novelty of this strategy, the field lacks a systematic evaluation of data processing methods and training strategies that maximize the benefits of mixed training data while accommodating the significant imbalance in the size of existing paired and unpaired datasets. Here, we introduce a method of curriculum learning for AbLMs, which facilitates a gradual transition from unpaired to paired sequences during training. We optimize this method and compare it to other data sampling strategies for AbLMs, including a constant mix and a fine-tuning approach. We observe that the curriculum and constant approaches show improved performance compared to the fine-tuning approach in large-scale models, likely due to their ability to prevent catastrophic forgetting and slow overfitting. Finally, we show that a 650M-parameter curriculum model, CurrAb, outperforms existing mixed AbLMs in downstream residue prediction and classification tasks.

Indexed as

AntibodiesComputational BiologyCurriculumHumansMachine LearningAntibodies

Identifiers

PMID40934267
PMCPMC12468933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.